The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility

Chun Shik Shin, Prashant Mishra, Jeramie D. Watrous, Valerio Carelli, Marilena D'Aurelio, Mohit Jain, David C. Chan

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

As noted by Warburg, many cancer cells depend on the consumption of glucose. We performed a genetic screen to identify factors responsible for glucose addiction and recovered the two subunits of the xCT antiporter (system xc -), which plays an antioxidant role by exporting glutamate for cystine. Disruption of the xCTantiporter greatly improves cell viability after glucose withdrawal, because conservation of glutamate enables cells to maintain mitochondrial respiration. In some breast cancer cells, xCT antiporter expression is upregulated through the antioxidant transcription factor Nrf2 and contributes to their requirement for glucose as a carbon source. In cells carrying patient-derived mitochondrial DNA mutations, the xCT antiporter is upregulated and its inhibition improves mitochondrial function and cell viability. Therefore, although upregulation of the xCT antiporter promotes antioxidant defence, it antagonizes glutamine metabolism and restricts nutrient flexibility. In cells with mitochondrial dysfunction, the potential utility of xCTantiporter inhibition should be further tested.

Original languageEnglish (US)
Article number15074
JournalNature Communications
Volume8
DOIs
StatePublished - Jan 1 2017

Fingerprint

glutamine
Antiporters
glutamates
Cystine
nutrients
metabolism
Glutamine
Metabolism
glucose
Nutrients
Glutamic Acid
flexibility
antioxidants
Cells
Glucose
Food
Antioxidants
viability
cancer
cells

ASJC Scopus subject areas

  • Chemistry(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Physics and Astronomy(all)

Cite this

The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility. / Shin, Chun Shik; Mishra, Prashant; Watrous, Jeramie D.; Carelli, Valerio; D'Aurelio, Marilena; Jain, Mohit; Chan, David C.

In: Nature Communications, Vol. 8, 15074, 01.01.2017.

Research output: Contribution to journalArticle

Shin, Chun Shik ; Mishra, Prashant ; Watrous, Jeramie D. ; Carelli, Valerio ; D'Aurelio, Marilena ; Jain, Mohit ; Chan, David C. / The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility. In: Nature Communications. 2017 ; Vol. 8.
@article{67018117cb324ed79efb8292f9444060,
title = "The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility",
abstract = "As noted by Warburg, many cancer cells depend on the consumption of glucose. We performed a genetic screen to identify factors responsible for glucose addiction and recovered the two subunits of the xCT antiporter (system xc -), which plays an antioxidant role by exporting glutamate for cystine. Disruption of the xCTantiporter greatly improves cell viability after glucose withdrawal, because conservation of glutamate enables cells to maintain mitochondrial respiration. In some breast cancer cells, xCT antiporter expression is upregulated through the antioxidant transcription factor Nrf2 and contributes to their requirement for glucose as a carbon source. In cells carrying patient-derived mitochondrial DNA mutations, the xCT antiporter is upregulated and its inhibition improves mitochondrial function and cell viability. Therefore, although upregulation of the xCT antiporter promotes antioxidant defence, it antagonizes glutamine metabolism and restricts nutrient flexibility. In cells with mitochondrial dysfunction, the potential utility of xCTantiporter inhibition should be further tested.",
author = "Shin, {Chun Shik} and Prashant Mishra and Watrous, {Jeramie D.} and Valerio Carelli and Marilena D'Aurelio and Mohit Jain and Chan, {David C.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1038/ncomms15074",
language = "English (US)",
volume = "8",
journal = "Nature Communications",
issn = "2041-1723",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - The glutamate/cystine xCT antiporter antagonizes glutamine metabolism and reduces nutrient flexibility

AU - Shin, Chun Shik

AU - Mishra, Prashant

AU - Watrous, Jeramie D.

AU - Carelli, Valerio

AU - D'Aurelio, Marilena

AU - Jain, Mohit

AU - Chan, David C.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - As noted by Warburg, many cancer cells depend on the consumption of glucose. We performed a genetic screen to identify factors responsible for glucose addiction and recovered the two subunits of the xCT antiporter (system xc -), which plays an antioxidant role by exporting glutamate for cystine. Disruption of the xCTantiporter greatly improves cell viability after glucose withdrawal, because conservation of glutamate enables cells to maintain mitochondrial respiration. In some breast cancer cells, xCT antiporter expression is upregulated through the antioxidant transcription factor Nrf2 and contributes to their requirement for glucose as a carbon source. In cells carrying patient-derived mitochondrial DNA mutations, the xCT antiporter is upregulated and its inhibition improves mitochondrial function and cell viability. Therefore, although upregulation of the xCT antiporter promotes antioxidant defence, it antagonizes glutamine metabolism and restricts nutrient flexibility. In cells with mitochondrial dysfunction, the potential utility of xCTantiporter inhibition should be further tested.

AB - As noted by Warburg, many cancer cells depend on the consumption of glucose. We performed a genetic screen to identify factors responsible for glucose addiction and recovered the two subunits of the xCT antiporter (system xc -), which plays an antioxidant role by exporting glutamate for cystine. Disruption of the xCTantiporter greatly improves cell viability after glucose withdrawal, because conservation of glutamate enables cells to maintain mitochondrial respiration. In some breast cancer cells, xCT antiporter expression is upregulated through the antioxidant transcription factor Nrf2 and contributes to their requirement for glucose as a carbon source. In cells carrying patient-derived mitochondrial DNA mutations, the xCT antiporter is upregulated and its inhibition improves mitochondrial function and cell viability. Therefore, although upregulation of the xCT antiporter promotes antioxidant defence, it antagonizes glutamine metabolism and restricts nutrient flexibility. In cells with mitochondrial dysfunction, the potential utility of xCTantiporter inhibition should be further tested.

UR - http://www.scopus.com/inward/record.url?scp=85022021432&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85022021432&partnerID=8YFLogxK

U2 - 10.1038/ncomms15074

DO - 10.1038/ncomms15074

M3 - Article

VL - 8

JO - Nature Communications

JF - Nature Communications

SN - 2041-1723

M1 - 15074

ER -